These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36380343)

  • 1. Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library.
    Offin M; Sauter JL; Tischfield SE; Egger JV; Chavan S; Shah NS; Manoj P; Ventura K; Allaj V; de Stanchina E; Travis W; Ladanyi M; Rimner A; Rusch VW; Adusumilli PS; Poirier JT; Zauderer MG; Rudin CM; Sen T
    Genome Med; 2022 Nov; 14(1):127. PubMed ID: 36380343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma.
    Wu L; Allo G; John T; Li M; Tagawa T; Opitz I; Anraku M; Yun Z; Pintilie M; Pitcher B; Liu G; Feld R; Johnston MR; de Perrot M; Tsao MS
    Clin Cancer Res; 2017 Feb; 23(4):1060-1067. PubMed ID: 27683181
    [No Abstract]   [Full Text] [Related]  

  • 3. Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts.
    Caeser R; Egger JV; Chavan S; Socci ND; Jones CB; Kombak FE; Asher M; Roehrl MH; Shah NS; Allaj V; Manoj P; Tischfield SE; Kulick A; Meneses M; Iacobuzio-Donahue CA; Lai WV; Bhanot U; Baine MK; Rekhtman N; Hollmann TJ; de Stanchina E; Poirier JT; Rudin CM; Sen T
    Nat Commun; 2022 Apr; 13(1):2144. PubMed ID: 35440124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
    Bonazzi VF; Kondrashova O; Smith D; Nones K; Sengal AT; Ju R; Packer LM; Koufariotis LT; Kazakoff SH; Davidson AL; Ramarao-Milne P; Lakis V; Newell F; Rogers R; Davies C; Nicklin J; Garrett A; Chetty N; Perrin L; Pearson JV; Patch AM; Waddell N; Pollock PM
    Genome Med; 2022 Jan; 14(1):3. PubMed ID: 35012638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.
    Kim S; Shin D; Min A; Kim M; Na D; Lee HB; Ryu HS; Yang Y; Woo GU; Lee KH; Lee DW; Kim TY; Lee C; Im SA; Kim JI
    J Transl Med; 2021 Jan; 19(1):7. PubMed ID: 33407601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.
    He F; Bandyopadhyay AM; Klesse LJ; Rogojina A; Chun SH; Butler E; Hartshorne T; Holland T; Garcia D; Weldon K; Prado LP; Langevin AM; Grimes AC; Sugalski A; Shah S; Assanasen C; Lai Z; Zou Y; Kurmashev D; Xu L; Xie Y; Chen Y; Wang X; Tomlinson GE; Skapek SX; Houghton PJ; Kurmasheva RT; Zheng S
    Nat Commun; 2023 Nov; 14(1):7600. PubMed ID: 37990009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors.
    Rajaram S; Roth MA; Malato J; VandenBerg S; Hann B; Atreya CE; Altschuler SJ; Wu LF
    Sci Data; 2019 Oct; 6(1):253. PubMed ID: 31672976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
    Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Personalized Therapeutic Strategies by Targeting Actionable Vulnerabilities in Metastatic and Chemotherapy-Resistant Breast Cancer PDXs.
    Punzi S; Meliksetian M; Riva L; Marocchi F; Pruneri G; Criscitiello C; Orsi F; Spaggiari L; Casiraghi M; Della Vigna P; Luzi L; Curigliano G; Pelicci PG; Lanfrancone L
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool.
    Villafranca-Magdalena B; Masferrer-Ferragutcasas C; Lopez-Gil C; Coll-de la Rubia E; Rebull M; Parra G; García Á; Reques A; Cabrera S; Colas E; Gil-Moreno A; Moiola CP
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
    Yu J; Qin B; Moyer AM; Sinnwell JP; Thompson KJ; Copland JA; Marlow LA; Miller JL; Yin P; Gao B; Minter-Dykhouse K; Tang X; McLaughlin SA; Moreno-Aspitia A; Schweitzer A; Lu Y; Hubbard J; Northfelt DW; Gray RJ; Hunt K; Conners AL; Suman VJ; Kalari KR; Ingle JN; Lou Z; Visscher DW; Weinshilboum R; Boughey JC; Goetz MP; Wang L
    Breast Cancer Res; 2017 Dec; 19(1):130. PubMed ID: 29212525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
    Sun H; Cao S; Mashl RJ; Mo CK; Zaccaria S; Wendl MC; Davies SR; Bailey MH; Primeau TM; Hoog J; Mudd JL; Dean DA; Patidar R; Chen L; Wyczalkowski MA; Jayasinghe RG; Rodrigues FM; Terekhanova NV; Li Y; Lim KH; Wang-Gillam A; Van Tine BA; Ma CX; Aft R; Fuh KC; Schwarz JK; Zevallos JP; Puram SV; Dipersio JF; ; Davis-Dusenbery B; Ellis MJ; Lewis MT; Davies MA; Herlyn M; Fang B; Roth JA; Welm AL; Welm BE; Meric-Bernstam F; Chen F; Fields RC; Li S; Govindan R; Doroshow JH; Moscow JA; Evrard YA; Chuang JH; Raphael BJ; Ding L
    Nat Commun; 2021 Aug; 12(1):5086. PubMed ID: 34429404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts.
    Moy RH; Walch HS; Mattar M; Chatila WK; Molena D; Strong VE; Tang LH; Maron SB; Coit DG; Jones DR; Hechtman JF; Solit DB; Schultz N; de Stanchina E; Janjigian YY
    JCO Precis Oncol; 2022 Feb; 6():e2100242. PubMed ID: 35138918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
    Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
    Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.
    Peng S; Creighton CJ; Zhang Y; Sen B; Mazumdar T; Myers JN; Lai SY; Woolfson A; Lorenzi MV; Bell D; Williams MD; Johnson FM
    J Transl Med; 2013 Aug; 11():198. PubMed ID: 23981300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
    Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR
    J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs).
    Patel KR; Espinoza AF; Urbicain M; Patel RH; Major A; Sarabia SF; Lopez-Terrada D; Vasudevan SA; Woodfield SE
    Pathol Res Pract; 2024 Mar; 255():155163. PubMed ID: 38394806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.
    Drapkin BJ; George J; Christensen CL; Mino-Kenudson M; Dries R; Sundaresan T; Phat S; Myers DT; Zhong J; Igo P; Hazar-Rethinam MH; Licausi JA; Gomez-Caraballo M; Kem M; Jani KN; Azimi R; Abedpour N; Menon R; Lakis S; Heist RS; Büttner R; Haas S; Sequist LV; Shaw AT; Wong KK; Hata AN; Toner M; Maheswaran S; Haber DA; Peifer M; Dyson N; Thomas RK; Farago AF
    Cancer Discov; 2018 May; 8(5):600-615. PubMed ID: 29483136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer.
    Woo XY; Srivastava A; Mack PC; Graber JH; Sanderson BJ; Lloyd MW; Chen M; Domanskyi S; Gandour-Edwards R; Tsai RA; Keck J; Cheng M; Bundy M; Jocoy EL; Riess JW; Holland W; Grubb SC; Peterson JG; Stafford GA; Paisie C; Neuhauser SB; Karuturi RKM; George J; Simons AK; Chavaree M; Tepper CG; Goodwin N; Airhart SD; Lara PN; Openshaw TH; Liu ET; Gandara DR; Bult CJ
    Cancer Res; 2022 Nov; 82(22):4126-4138. PubMed ID: 36069866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.